A

Ascent Therapeutics

1 employees

Ascent Therapeutics offers Pepducins targeting GPCRs on the cell membrane, expanding the GPCR frontier.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Medical

Date founded

2006

Funding rounds raised

Total raised

$19M

from 2 investors over 2 rounds

A

Ascent Therapeutics raised $19M on November 5, 2007

Investors: TVM Life Science Management Inc and HealthCare Ventures LLC

FAQ